awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26738514-7AA00022-D63A-4620-BC4D-F4F36B1651EC
Q26738514-7AA00022-D63A-4620-BC4D-F4F36B1651EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738514-7AA00022-D63A-4620-BC4D-F4F36B1651EC
Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned
P2860
Q26738514-7AA00022-D63A-4620-BC4D-F4F36B1651EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738514-7AA00022-D63A-4620-BC4D-F4F36B1651EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
93d2204f6cb0c4c852ef49b2c20e390c4ea9a815
P2860
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.